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Organization, 2003). Efforts to limit 
 pneumococcal disease have focused pri-
marily on antibiotic intervention and vac-
cination. However, after initial, and often 
dramatic, successes the effectiveness of these 
measures has consistently been overcome 
by the extremely adaptable and resilient 
pneumococcus. S. pneumoniae is naturally 
competent and readily incorporates DNA 
fragments derived from pneumococcal 
and non-pneumococcal bacterial species 
into its genome by homologous recom-
bination. High levels of recombination 
have resulted in extreme diversity within 
pneumococcal populations from which 
variant genotypes can rapidly emerge in 
the presence of changing selective pressures. 
The primary pressures outside of natural 
immunity are antibiotics and pneumo-
coccal conjugate polysaccharide vaccines. 
Resistant and multidrug resistant pneu-
mococci have emerged since the late 1960s 
and now severely limit treatment options 
for pneumococcal diseases (Reinert, 2009). 
The incidences of invasive pneumococcal 
disease (IPD) and antibiotic resistant pneu-
mococci decreased dramatically following 
the introduction of the heptavalent conju-
gate vaccine PCV7 in 2000 (Dagan, 2009). 
However, the incidence of IPD and resist-
ance is again rising due to the emergence of 
multidrug resistant, non-vaccine “replace-
ment” serotypes.
Croucher et al. (2011) documented the 
“escape” of the PMEN1 clone from PCV7 
by indentifying several independent 
horizontal transfer events that resulted 
in serotype switching of PMEN1 strains 
from vaccine serotype 23F to non-vaccine 
serotypes. This suggested strong selec-
tive pressures for capsule switch variants 
exerted by the PCV7-immunized human 
immune system. Evidence for the selective 
pressures exerted by antibiotics was also 
reported. Analysis of integrative and con-
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The landmark paper recently published 
by Croucher et al. (2011) reports the draft 
genome sequencing of 240 Streptococcus 
pneumoniae isolates and demonstrates the 
power of comparative genomics in the epi-
demiological and phylogenetic analysis of 
bacterial pathogens.
Until recently, the focus of bacte-
rial genome projects has been individual 
strains or small numbers of clinical isolates. 
However, with the advent of next genera-
tion sequencing platforms such as Roche 
454 and Illumina, bacterial genomes can 
be inexpensively and rapidly sequenced. 
The first large-scale genomic sequencing 
project to utilize these technologies for a 
similar purpose (also by the Bentley group) 
analyzed 63 clonally related methicillin-
resistant Staphylococcus aureus isolates 
(Harris et al., 2010). Croucher et al. (2011) 
analyzed temporally and geographically 
diverse isolates of a single S. pneumoniae 
lineage, the multidrug resistant Spain 23F 
ST81 (PMEN1) pandemic clone, to provide 
insights into the microevolution of this 
important pathogen.
Streptococcus pneumoniae is a major 
worldwide public health concern. It is 
responsible for an estimated 1.6 million 
deaths each year, half of which are chil-
dren under the age of five (World Health 
jugative elements revealed rapid degener-
ation of such elements but with consistent 
retention of determinants of resistance to 
antibiotics commonly used in treatment 
of upper respiratory infections (e.g., 
b-lactams and macrolides). It should 
be expected that the pneumococcus will 
adapt quickly to new antibiotic pres-
sures and vaccines such as the 13-valent 
PCV vaccine (PCV13) introduced in the 
United States early 2010. This emphasizes 
the importance of surveillance and epide-
miology to track the emergence of new 
clones and variations.
In addition to overcoming clinical 
interventions, the plasticity of the pneu-
mococcal genome has confounded epide-
miological analyses. Multilocus sequence 
typing (MLST) is currently the preferred 
method for comparing relatedness of 
isolates within a given bacterial species, 
and relies on sequence comparison of 
seven highly conserved alleles. However, 
the high rate of recombination in pneu-
mococci greatly reduces the resolution 
of MLST-derived pneumococcal phyl-
ogenies due to horizontal acquisition of 
single nucleotide polymorphisms (SNPs) 
by recombination events involving MLST 
alleles. Croucher et al. (2011) avoided 
this problem by removing horizontally 
inherited sequences from the phyloge-
netic analyses. Recombination events 
were identified by comparison of each 
genome to a Spain 23F ST81 reference 
genome (ATCC 700669; Croucher et al., 
2009). The phylogeny constructed using 
only vertically inherited SNPs proved to 
be a superior estimation of the evolu-
tion of the clone based on the correla-
tion between the distance from the root 
of the tree and the date of isolation of 
each strain. By comparing the more accu-
rate phylogeny to the dates and locations 
of isolation, the authors were able to 
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invasive disease as well as inter- and intra-
species horizontal gene transfer in S. pneu-
moniae. Similarly, study of the evolution of 
pneumococcal isolates within a single host 
will help define risks of acquired antibi-
otic resistance in the presence of antibiotic 
therapy and other interventions.
Current and next generation tech-
nologies will be invaluable for epidemi-
ologists and microbiologists studying 
non- pneumococcal pathogens, and com-
mensals. Large-scale genomic analyses may 
lead to identification of novel therapeutic 
agents and new vaccine targets. Croucher 
et al. (2011) are one of the first groups to 
realize the full potential of the develop-
ments in DNA sequencing technologies 
that powered these large scale comparative 
genomic projects. This report signals the 
beginning of an era of discovery that will 
lead to comprehensive understanding of 
bacterial evolution, will revolutionize epi-
demiology, and allow the development of 
more effective and longer lasting strategies 
to treat infectious diseases.
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 pinpoint the likely origins of different 
clades and to discern information about 
the geographic spread of the clone.
Future studies utilizing large-scale genomic 
comparison in S. pneumoniae will likely focus 
on the influence of antibiotic and vaccine 
pressures and on the evolution of pneu-
mococcal populations. Whereas Croucher 
et al. (2011) utilized “deep” sequencing into 
a single lineage, “wide” genomic analysis of 
isolates that encompass entire pneumococ-
cal populations will provide insights into the 
evolution and interactions of multiple line-
ages. In addition, it will elucidate the effects 
of localized factors such as host population 
genetic composition and confounding health 
and socioeconomic factors. In particular, it 
will clarify the effects of vaccine and antibi-
otic pressures on the population and identify 
candidate lineages for deep sequencing.
Sequencing technologies have also 
enabled analysis of entire bacterial popu-
lations in individual niches, such as the 
Human Microbiome Project (HMP). The 
HMP attempts to elucidate the composition 
and role of the microbiota that inhabit the 
human body. Such studies in the nasophar-
ynx will provide a better understanding 
of the role of pneumococcal carriage in 
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